Brucine-Loaded Nanoparticles: Advancements in Targeted Drug Delivery Systems
DOI:
https://doi.org/10.22270/ajprd.v11i3.1424Abstract
Brucine-loaded nanoparticles represent a significant advancement in drug delivery systems, leveraging the pharmacological properties of brucine, an alkaloid derived from the Strychnos nux-vomica plant. This study aimed to develop and assess the efficacy of brucine-loaded nanoparticles in advancing drug delivery systems. Nanoparticles, as carriers, offer a versatile platform for controlled and targeted drug delivery. They were meticulously crafted using biocompatible materials and thoroughly characterized for their physicochemical attributes, drug loading efficiency, and release kinetics. Techniques such as UV spectroscopy, Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), field-emission scanning electron microscopy (FESEM), and differential scanning calorimetry (DSC) were employed for comprehensive characterization. Surface modification with targeting ligands facilitated the precise delivery of brucine to specific cells or tissues, thereby enhancing therapeutic efficacy while minimizing off-target effects. studies provided valuable insights into the biodistribution and pharmacokinetics of the nanoparticles, underscoring their potential in advancing drug delivery systems. Overall, the findings highlight the significant role of brucine-loaded nanoparticles in advancing drug delivery systems, promising remarkable advancements in nanoparticle-based therapeutics.
Downloads
References
Lu L, Huang R, Wu Y, Jin JM, Chen HZ, Zhang LJ, Luan X. Brucine: a review of phytochemistry, pharmacology, and toxicology.
Frontiers in Pharmacology. 2020 Apr 3;11:377.
QIN XQ, Yuan Y, LIU CS, WANG QY, Shen X, YANG BC. Preparation of liposomal brucine and its pharmaceutical/pharmacodynamic characterization 1. Acta Pharmacologica Sinica. 2007 Nov;28(11):1851-8.
Li S, Wang XP. In vitro and in vivo Evaluation of Novel NGR-Modified Liposomes Containing Brucine [Retraction]. International Journal of Nanomedicine. 2022 Nov 18;17:5489-90.
Wu P, Liang Q, Feng P, Li C, Yang C, Liang H, Tang H, Shuai C. A novel brucine gel transdermal delivery system designed for anti-inflammatory and analgesic activities. International Journal of Molecular Sciences. 2017 Apr 3;18(4):757.
Tang M, Zhu WJ, Yang ZC, He CS. Brucine inhibits TNF α induced HFLS RA cell proliferation by activating the JNK signaling pathway. Experimental and Therapeutic Medicine. 2019 Jul 1;18(1):735-40.
Witika BA, Mweetwa LL, Tshiamo KO, Edler K, Matafwali SK, Ntemi PV, Chikukwa MT, Makoni PA. Vesicular drug delivery for the treatment of topical disorders: Current and future perspectives. Journal of Pharmacy and Pharmacology. 2021 Nov 1;73(11):1427-1441.
Prabhjot K, Loveleenpreet K. Nanoparticles used as Targeting Drug Delivery System: A Overview. Asian Journal of Research in Chemistry. 2014;7(7):687-692.
Khanam N, Sachan AK, Alam MI, Gangwar SS, Sharma R. Recent trends in drug delivery by nanoparticles: a review. Asian journal of pharmaceutical research and development. 2013 May 1:115-122.
More VV. Niosomal drug delivery-a comprehensive review. Asian Journal of Pharmaceutics (AJP). 2018;12(04).
Yadav JD, Kulkarni PR, Vaidya KA, Shelke GT. Nanoparticles: a review. Journal of Pharmacy Research. 2011 Mar;4(3):632-636.
Thabet Y, Elsabahy M, Eissa NG. Methods for preparation of nanoparticles: A focus on thin-film hydration method. Methods. 2022 Mar 1;199:9-15.
Akbari J, Saeedi M, Morteza-Semnani K, Hashemi SM, Babaei A, Eghbali M, Mohammadi M, Rostamkalaei SS, Asare-Addo K, Nokhodchi A. Innovative topical niosomal gel formulation containing diclofenac sodium (niofenac). Journal of Drug Targeting. 2022 Jan 2;30(1):108-17.
El-Nabarawi MA, Abd El Rehem RT, Teaima M, Abary M, El-Mofty HM, Khafagy MM, Lotfy NM, Salah M. Natamycin nanoparticles as a promising ocular nanosized delivery system with ketorolac tromethamine for dual effects for treatment of candida rabbit keratitis; in vitro/in vivo and histopathological studies. Drug development and industrial pharmacy. 2019 Jun 3;45(6):922-936.
Alnaim AS, Shah H, Nair AB, Mewada V, Patel S, Jacob S, Aldhubiab B, Morsy MA, Almuqbil RM, Shinu P, Shah J. Qbd-based approach to optimize niosomal gel of levosulpiride for transdermal drug delivery. Gels. 2023 Mar 10;9(3):213.
Mohamed A, Bendas ER, Mohamed S, Abdel-Jaleel GA, Nasr-Alla SM. Formulation and evaluation of topical niosomal gel of baclofen. J Chem Pharm Res. 2015;7(1):277-88.
Ghumman SA, Ijaz A, Noreen S, Aslam A, Kausar R, Irfan A, Latif S, Shazly GA, Shah PA, Rana M, Aslam A. Formulation and characterization of curcumin nanoparticles: Antioxidant and cytotoxicity studies. Pharmaceuticals. 2023 Oct 3;16(10):1406.
El-Ridy MS, Yehia SA, Mohsen AM, El-Awdan SA, Darwish AB. Formulation of niosomal gel for enhanced transdermal lornoxicam delivery: in-vitro and in-vivo evaluation. Current Drug Delivery. 2018 Jan 1;15(1):122-33.
Sammour RM, Taher M, Chatterjee B, Shahiwala A, Mahmood S. Optimization of aceclofenac pronanoparticles by using different carriers, part 1: Development and characterization. Pharmaceutics. 2019 Jul 18;11(7):350.
Prasad LG, Krishnakumar V, Jothi M, Nagalakshmi R. Spectroscopic and physicochemical studies on organic crystal of brucine hydrogen maleate pentahydrate. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2010 Sep 15;77(1):87-91
Published
How to Cite
Issue
Section
Copyright (c) 2024 Mandal Priyanka, Dhoble Nilakshi, Padole Nitin, Dhapke Pankaj, Baheti Jagdish
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.